Bimatoprost vs Latanoprost: side-by-side comparison
Bimatoprost and Latanoprost belong to the same class (Prostaglandin analogue). They share therapeutic approach but differ in mechanism nuances, half-life, side-effect profile and available formulations. This comparison summarises what is common and where they diverge.
| Property | Bimatoprost | Latanoprost |
|---|---|---|
| Therapeutic class | Prostaglandin analogue | Prostaglandin analogue |
| CAS | 155206-00-1 | 130209-82-4 |
| ATC | S01EE03 | S01EE01 |
| Molecular weight | 415.57 g/mol | 432.59 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Both are in the Prostaglandin analogue class, giving them a common pharmacological architecture and many shared safety and management points. Choice within the class comes down to mechanism nuances, half-life, side-effect profile and individual response.
Key differences
Differences within the Prostaglandin analogue class are what matter in practice: half-life, route of administration, equivalent doses, specific interactions, predominant side-effect profile and accumulated clinical experience. This page frames them; the prescribing information gives quantitative detail.
Mechanisms compared
Bimatoprost: Bimatoprost is a prostamide analogue that increases aqueous humour outflow through both the trabecular meshwork and the uveoscleral pathway, lowering intraocular pressure. Latanoprost: Latanoprost is a prodrug ester hydrolysed by corneal esterases to its active free acid, which selectively binds the prostaglandin F (FP) receptor.
Indications compared
Bimatoprost: Bimatoprost is approved in adults for the treatment of ocular hypertension and chronic open-angle glaucoma. Latanoprost: Latanoprost is approved in adults and children for the treatment of ocular hypertension and chronic open-angle glaucoma.
Safety profile
Bimatoprost: Common adverse effects include conjunctival hyperaemia, ocular irritation, eyelash growth and darkening, and progressive iris pigmentation, which is permanent. Latanoprost: Common adverse effects include conjunctival hyperaemia, ocular irritation, eyelash growth and darkening, and progressive iris pigmentation, which is permanent.
Frequently asked questions
Is Bimatoprost better than Latanoprost? ▾
Neither is universally better. Bimatoprost and Latanoprost share the Prostaglandin analogue class but differ in half-life, mechanism nuances and side-effect profile. The choice depends on the patient and the prescriber.
Can Bimatoprost and Latanoprost be combined? ▾
Combining two ingredients from the same Prostaglandin analogue class is uncommon and, in most cases, adds no benefit over one at an appropriate dose. The decision is always the prescriber's.
Do they have the same side-effect profile? ▾
Partly yes — they share many Prostaglandin analogue class effects, with nuances by mechanism and dose. The prescribing information lists differences.
Products with Bimatoprost
Products with Latanoprost
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.